Traditional Chinese medicine electuary for treatment and nursing of ICU myasthenia gravis and preparation method

Abstract

The invention discloses traditional Chinese medicine electuary for treatment and nursing of ICU myasthenia gravis and a preparation method and belongs to the field of traditional Chinese medicine. The traditional Chinese medicine electuary is prepared from ficus beecheyana hook, Chinese dates, uncaria roots, mucuna sempervirens, triple shot range, milkvetch roots, ventilago leiocarpa benth, silverweed cinquefoil roots, wild black soybeans, lotus leaves, tuber fleeceflower stems, liquorice, akebiaquinata roots, pawpaws, cynachum uilfordii hemsl, radix paeoniae alba, glossy privet fruits, radix angelicae pubescentis, rattlesnake plantain, Sichuan cinnamon, cortex acanthopanacis, fructus amomi, gynostemma pentaphylla and antelope's horns. The medicine properties of the selected medicinal materials are adaptive and complementary, the medicine is applied pointing to symptoms according to pathogenesis, the effects of tonifying the liver and kidney, tonifying the spleen and raising yang, invigorating qi and blood, strengthening tendons and bones, relaxing tendons and activating collaterals and promoting qi to activate blood are achieved, the absorption effect is good, the curative effect is remarkable, no toxic or side effect or clinical adverse reaction is generated, and the traditional Chinese medicine electuary is high in cure rate for myasthenia gravis through clinical verification.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to traditional Chinese medicine granules used for the treatment and nursing of ICU myasthenia gravis and a preparation method thereof. Background technique [0002] Myasthenia gravis (MG) is an autoimmune disease caused by dysfunction of the nerve-muscle junction. The main clinical manifestations are partial or general skeletal muscle weakness and easy fatigue. The symptoms are aggravated after activities and relieved after rest. . The prevalence rate is 77-150 / 1 million, and the annual incidence rate is 4-11 / 1 million. The disease is more common in women than men and usually begins between the ages of 20 and 40, but can occur at any age. The most common symptoms are weakness of the eyelids (ptosis), weakness of the eye muscles, which can cause double vision, and muscles that tire especially after activities. In patients with myasthenia gravis, the eye muscles are aff...

AI Technical Summary

Problems solved by technology

At present, for the treatment of myasthenia gravis, the commonly used drugs in Western medicine such as anticholinesterase drugs, immunosuppressants, hormones and biological agents, or surgical treatment can temporarily relieve the symptoms, but they often treat the symptoms but not the root cause, and are prone to recurrence. Long-term use is likely to produce dependence and drug resistance, and the side effects are large. If it is not treated for a long time or it is not easy to recover in the late stage

[0004] Myasthenia gravis belongs to the category of "fistula syndrome" in traditional Chinese medicine. It is a disease characterized by drooping eyelids, weakness of limbs, light in the morning and heavy in the evening, progressive aggravation or accompanied by dysphagia and unclear articulation. Deficiency, so the treatment is mainly based on strengthening the spleen and kidney, nourishing qi and nourishing yin, and achieved good curative effect, but the treatment cycle is long

Images